Glucocorticoid receptor expression in breast cancer associates with older patient age

Larissa Belova, Bertha Delgado, Masha Kocherginsky, Amal Melhem, Olufunmilayo I. Olopade, Suzanne D. Conzen

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Breast cancer can be classified according to estrogen (ER), progesterone (PR), and HER2 receptor expression. Recent evidence suggests that activation of the glucocorticoid receptor (GR) contributes to breast cell survival, although the incidence of GR expression in primary human breast tumors is not well established. We therefore evaluated ER, PR, HER2, and GR by immunohistochemistry from 231 patients and found that while African American (AA) patient tumors were much more likely to be ER negative compared to tumors from non-AA patients, GR expression was significantly higher in tumors from patients ≥50 regardless of ancestry. Prospective examination of GR expression in tumors should be considered to determine whether GR contributes to longterm clinical outcome.

Original languageEnglish (US)
Pages (from-to)441-447
Number of pages7
JournalBreast Cancer Research and Treatment
Volume116
Issue number3
DOIs
StatePublished - Aug 1 2009
Externally publishedYes

Fingerprint

Glucocorticoid Receptors
Breast Neoplasms
Estrogens
Progesterone Receptors
Neoplasms
African Americans
Cell Survival
Breast
Immunohistochemistry
Incidence

Keywords

  • Estrogen receptor
  • Glucocorticoid receptor
  • Health disparities
  • HER2
  • Progesterone receptor
  • Triple-negative disease

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Glucocorticoid receptor expression in breast cancer associates with older patient age. / Belova, Larissa; Delgado, Bertha; Kocherginsky, Masha; Melhem, Amal; Olopade, Olufunmilayo I.; Conzen, Suzanne D.

In: Breast Cancer Research and Treatment, Vol. 116, No. 3, 01.08.2009, p. 441-447.

Research output: Contribution to journalArticle

Belova, Larissa ; Delgado, Bertha ; Kocherginsky, Masha ; Melhem, Amal ; Olopade, Olufunmilayo I. ; Conzen, Suzanne D. / Glucocorticoid receptor expression in breast cancer associates with older patient age. In: Breast Cancer Research and Treatment. 2009 ; Vol. 116, No. 3. pp. 441-447.
@article{cf14d2effa3f47748c5d9c6c005bf42e,
title = "Glucocorticoid receptor expression in breast cancer associates with older patient age",
abstract = "Breast cancer can be classified according to estrogen (ER), progesterone (PR), and HER2 receptor expression. Recent evidence suggests that activation of the glucocorticoid receptor (GR) contributes to breast cell survival, although the incidence of GR expression in primary human breast tumors is not well established. We therefore evaluated ER, PR, HER2, and GR by immunohistochemistry from 231 patients and found that while African American (AA) patient tumors were much more likely to be ER negative compared to tumors from non-AA patients, GR expression was significantly higher in tumors from patients ≥50 regardless of ancestry. Prospective examination of GR expression in tumors should be considered to determine whether GR contributes to longterm clinical outcome.",
keywords = "Estrogen receptor, Glucocorticoid receptor, Health disparities, HER2, Progesterone receptor, Triple-negative disease",
author = "Larissa Belova and Bertha Delgado and Masha Kocherginsky and Amal Melhem and Olopade, {Olufunmilayo I.} and Conzen, {Suzanne D.}",
year = "2009",
month = "8",
day = "1",
doi = "10.1007/s10549-008-0136-9",
language = "English (US)",
volume = "116",
pages = "441--447",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Glucocorticoid receptor expression in breast cancer associates with older patient age

AU - Belova, Larissa

AU - Delgado, Bertha

AU - Kocherginsky, Masha

AU - Melhem, Amal

AU - Olopade, Olufunmilayo I.

AU - Conzen, Suzanne D.

PY - 2009/8/1

Y1 - 2009/8/1

N2 - Breast cancer can be classified according to estrogen (ER), progesterone (PR), and HER2 receptor expression. Recent evidence suggests that activation of the glucocorticoid receptor (GR) contributes to breast cell survival, although the incidence of GR expression in primary human breast tumors is not well established. We therefore evaluated ER, PR, HER2, and GR by immunohistochemistry from 231 patients and found that while African American (AA) patient tumors were much more likely to be ER negative compared to tumors from non-AA patients, GR expression was significantly higher in tumors from patients ≥50 regardless of ancestry. Prospective examination of GR expression in tumors should be considered to determine whether GR contributes to longterm clinical outcome.

AB - Breast cancer can be classified according to estrogen (ER), progesterone (PR), and HER2 receptor expression. Recent evidence suggests that activation of the glucocorticoid receptor (GR) contributes to breast cell survival, although the incidence of GR expression in primary human breast tumors is not well established. We therefore evaluated ER, PR, HER2, and GR by immunohistochemistry from 231 patients and found that while African American (AA) patient tumors were much more likely to be ER negative compared to tumors from non-AA patients, GR expression was significantly higher in tumors from patients ≥50 regardless of ancestry. Prospective examination of GR expression in tumors should be considered to determine whether GR contributes to longterm clinical outcome.

KW - Estrogen receptor

KW - Glucocorticoid receptor

KW - Health disparities

KW - HER2

KW - Progesterone receptor

KW - Triple-negative disease

UR - http://www.scopus.com/inward/record.url?scp=70349570432&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349570432&partnerID=8YFLogxK

U2 - 10.1007/s10549-008-0136-9

DO - 10.1007/s10549-008-0136-9

M3 - Article

C2 - 18668364

AN - SCOPUS:70349570432

VL - 116

SP - 441

EP - 447

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 3

ER -